Bill Commons

VA HB 1025

Status unknown

Access to investigational drugs, etc.; patient with severely debilitating condition.

Virginia · 2026 Regular Session · lower

Follow this bill’s action updates (Atom)

Subscribe in a feed reader. The feed covers recorded actions from the last 30 days; Bill Commons may record an action after it happened at the legislature.

Quick answers

Did VA HB 1025 pass?

The current status of VA HB 1025 is not known from the official record. Latest recorded action (2026-02-18): Left in Committee Health and Human Services

What is VA HB 1025 about?

Access to investigational drugs, biological products, and devices; patient with severely debilitating condition. Allows a patient who has a severely debilitating condition, defined in the bill as a disease or condition that causes major irreversible morbidity, to access investigational drugs, biological products, and devices when certain criteria are met. Under current law, only a patient who has a terminal condition may access such drugs, products, and devices.

Who sponsors VA HB 1025?

Wendell S. Walker is the primary sponsor of VA HB 1025, joined by 1 cosponsor.

Description

Access to investigational drugs, biological products, and devices; patient with severely debilitating condition. Allows a patient who has a severely debilitating condition, defined in the bill as a disease or condition that causes major irreversible morbidity, to access investigational drugs, biological products, and devices when certain criteria are met. Under current law, only a patient who has a terminal condition may access such drugs, products, and devices.

Introduced
2026-01-14
Latest action
2026-02-18 — Left in Committee Health and Human Services
Bill type
bill
Last updated
—

Sponsors

  • Wendell S. Walkerprimary
  • Wren M. Williamscosponsor

Committees

Not provided by source.

Action timeline

Newest first

  1. 2026-02-18

    Left in Committee Health and Human Services

  2. 2026-02-10

    Subcommittee recommends laying on the table (7-Y 1-N)

  3. 2026-02-05

    Fiscal Impact Statement from Department of Planning and Budget (HB1025)

  4. 2026-01-23

    Assigned sub: Health

    referral-committee

  5. 2026-01-14

    Referred to Committee on Health and Human Services

    referral-committee

  6. 2026-01-14

    Prefiled and ordered printed; Offered 01-14-2026 26102452D

    filing,introduction

Versions

Documents

Votes

  • Subcommittee recommends laying on the table

    2026-02-10 · pass · 7-1

    Member-level votes (10)
    • Patrick A. Hope: yes
    • Marcia S. "Cia" Price: yes
    • Sam Rasoul: not voting
    • Charniele L. Herring: yes
    • Irene Shin: yes
    • Mark C. Downey: yes
    • Garrett McGuire: yes
    • M. Keith Hodges: not voting
    • Wendell S. Walker: no
    • H. Otto Wachsmann, Jr.: yes

Related bills

No related bills recorded for this bill.

Official source

Attribution

Data from openstates_bulk_csv, retrieved 2026-07-24T05:35:59.552682Z

Inspect retained evidence for changes recorded after evidence tracking began:

Session-wide evidence can include changes to other bills:

Use this data

Every field on this page is available from the free public API — no key or licence required. Fetch this bill as JSON: GET /api/v1/bills?jurisdiction=VA&identifier=HB 1025. See the API docs or the MCP server for AI assistants.

Known limitations

  • Sponsor party and chamber affiliation are not yet captured by this API.
  • Committee referrals are not yet captured.

See the methodology page for data sources and limitations.